|
Dear Edson Neto, |
Because you cited the paper "Miss Rate of Lung Cancer on the Chest Radiograph in Clinical Practice<xref rid="AFF1"><sup>*</sup></xref>", we think you might be interested in this published article from Academia Oncology: Monitoring for pneumonitis in breast cancer patients treated with trastuzumab deruxtecan: a single-centre experience
|
|
|
Olivia S. Walker, Edward Phillips, Simon Rodney, Monica Esteban, Michael Arango, Benjamin Thwaites, Zoe Kemp...
|
|
|
|---|
|
|---|
|
| <bold>Background:</bold> Trastuzumab deruxtecan (T-DXd) is a highly effective treatment for human epidermal growth factor receptor 2 (HER2)-positive and HER2-low advanced breast cancer. Following two fatal pneumonitis cases within 6 months of introducing T-DXd, we implemented more intensive monitoring, including... Read more |
|
|
|---|
|
|
Academia Oncology is an innovative open access journal publishing original research and review articles covering all areas of oncology. The editors welcome interdisciplinary submissions from the cutting edge of oncology research, in particular, those that drive connectivity between disciplines. |
|
|
|---|
|
|
|
|
Read later